Emphysema, and lung cancer patients should seriously consider surgery to levy

According to British scholar, after one second past the expected rate ppoFEV1 <40% of the patients with lung cancer usually does not advocate surgery, but the latest study found that the lung cancer patients with emphysema ppoFEV1 calculated accurately, therefore their operation Indications should be reconsidered.
Leicester City Glenfield Hospital DA Waller and colleagues of 29 cases of lung cancer patients with emphysema after lobectomy efficacy were evaluated, of which 14 were ppoFEV1 <40%> 40% ( Group B).
The results showed that in Group B in FEV1 Perioperative significantly reduced, and no group A of the phenomenon. Despite ppoFEV1 different, but after surgery in March FEV1 were no significant differences. In addition, within 30 days after two deaths in group A, while in group B did not. Nevertheless, the average survival time were similar.
Moreover, for emphysema patients, the removal of non-functional lung tissue can sometimes improve their postoperative pulmonary function. Therefore, the standard ppoFEV1 calculation method may have underestimated its value after the real FEV1.
Dr. Waller pointed out that when the decision on the lung cancer patients with emphysema for tumor resection, surgery should be considered due to lung volume reduction of its impact. He suggested that clinical ppoFEV1 for 40% of the surgical critical point should not continue to apply to such patients.